Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands |
Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Total |
|||
|---|---|---|---|---|---|---|---|
| Balance at Dec. 31, 2019 | $ 7 | [1] | $ 38,149 | $ (29,240) | $ 8,916 | ||
| Balance (in Shares) at Dec. 31, 2019 | [1] | 6,788 | |||||
| Net income | 2,861 | 2,861 | |||||
| Share-based compensation expense | [1] | 87 | 87 | ||||
| Share-based compensation expense (in Shares) | [1] | ||||||
| Balance at Dec. 31, 2020 | $ 7 | [1] | 38,236 | (26,379) | 11,864 | ||
| Balance (in Shares) at Dec. 31, 2020 | [1] | 6,788 | |||||
| Net income | 1,414 | 1,414 | |||||
| Exercise of warrants | [1] | ||||||
| Exercise of warrants (in Shares) | [1] | 152 | |||||
| Exercise of stock options (Note 9) | [1] | (23) | (23) | ||||
| Exercise of stock options (Note 9) (in Shares) | [1] | 67 | |||||
| Share-based compensation expense | [1] | 1,003 | 1,003 | ||||
| Share-based compensation expense (in Shares) | [1] | ||||||
| Balance at Dec. 31, 2021 | $ 7 | [1] | $ 39,216 | $ (24,965) | $ 14,258 | ||
| Balance (in Shares) at Dec. 31, 2021 | [1] | 7,007 | |||||
| |||||||